ReviewHuman vaccines & immunotherapeutics2016
Healthy adult vaccination: An urgent need to prevent hepatitis B in China.
Review in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Vaccination coverage of hepatitis B and associated factors among health care workers in Gansu province.Human vaccines & immunotherapeutics · 2024Article
- Understanding stigma and attitudes towards hepatitis B among university students in Australia of Chinese and Vietnamese background.BMC public health · 2024Article
- Spatial-temporal analysis of hepatitis B in Fujian Province, China in 2012-2021.Infectious medicine · 2024Article
- Spatiotemporal and Seasonal Trends of Class A and B Notifiable Infectious Diseases in China: Retrospective Analysis.JMIR public health and surveillance · 2023Article
- Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children.Human vaccines & immunotherapeutics · 2022Article
- Article
- Article
- Article
- The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China.Human vaccines & immunotherapeutics · 2021Article
- Epidemiological characteristics and trends of notifiable infectious diseases in China from 1986 to 2016.Journal of global health · 2020Article
- Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study.Human vaccines & immunotherapeutics · 2020Article
- Hepatitis B virus serological screen in a general hospital in Beijing from 2008 to 2018, and challenges to our vaccination policy.Vaccine: X · 2020Article
- ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study.Frontiers in oncology · 2020Article
- Study on Status and Willingness towards Hepatitis B Vaccination among Migrant Workers in Chongqing, China: A Cross-Sectional Study.International journal of environmental research and public health · 2019Article
- Spatio-Temporal Epidemiology of Viral Hepatitis in China (2003-2015): Implications for Prevention and Control Policies.International journal of environmental research and public health · 2018Article
- Influences of obesity on the immunogenicity of Hepatitis B vaccine.Human vaccines & immunotherapeutics · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prevalence of hepatitis B is still high among adults in China, athough the prevalence in children has decreased dramatically. Immunization against hepatitis B among adults is urgently required. Through analyzing the immunogenicity of different doses, schedules and booster immunization among adults, we recommend 10 or 20 μg with a 0-1-6-month schedule or a 0-1-12-month schedule for migrant adults. For immunity failure, increasing the dose or covalent vaccine is suggested to provide protective antibodies. To enhance immunity among adults, hepatitis B vaccine should be included in health insurance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.